Literature DB >> 8383482

Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders.

J W Tervaert1, L Mulder, C Stegeman, J Elema, M Huitema, H The, C Kallenberg.   

Abstract

Antineutrophil cytoplasmic antibodies (ANCAs) constitute a new class of autoantibodies that seem to recognise myeloid lysosomal enzymes. The occurrence of ANCAs with specificity for human leucocyte elastase (HLE) was assessed in serum samples that were routinely submitted for ANCA determination. During a study period of more than six years anti-HLE was found in only six out of 1102 serum samples that produced a perinuclear or an atypical cytoplasmic staining pattern on ethanol fixed granulocytes. These six serum samples were from four patients with a clinical diagnosis of Wegener's granulomatosis but without a definite histological diagnosis, one patient with systemic vasculitis, and one patient with Cogan's syndrome. To further evaluate the prevalence of anti-HLE we tested 315 serum samples from patients with different forms of vasculitis and related disorders. Anti-HLE was detected in two patients only. Thus autoantibodies to HLE are rarely found in serum samples from patients with vasculitic or related disorders.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383482      PMCID: PMC1004989          DOI: 10.1136/ard.52.2.115

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  30 in total

1.  Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases.

Authors:  J W Tervaert; A H Mulder; G Horst; E B Haagsma; J H Kleibeuker; C G Kallenberg
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

2.  Delineation of a standard procedure for indirect immunofluorescence detection of ANCA.

Authors:  A Wiik
Journal:  APMIS Suppl       Date:  1989

3.  Indirect immunofluorescence examination for IgG-ANCA in sera submitted for the 1st international workshop on ANCA, 1988.

Authors:  N Rasmussen; A Wiik
Journal:  APMIS Suppl       Date:  1989

4.  Circulating anti-elastase in systemic lupus erythematosus.

Authors:  L Nässberger; H Jonsson; A G Sjöholm; G Sturfelt; A Heubner
Journal:  Lancet       Date:  1989-03-04       Impact factor: 79.321

5.  The pulmonary biopsy in the early diagnosis of Wegener's (pathergic) granulomatosis: a study based on 35 open lung biopsies.

Authors:  E J Mark; O Matsubara; N S Tan-Liu; R Fienberg
Journal:  Hum Pathol       Date:  1988-09       Impact factor: 3.466

6.  Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase.

Authors:  J L Niles; R T McCluskey; M F Ahmad; M A Arnaout
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

7.  The protracted superficial phenomenon in pathergic (Wegener's) granulomatosis.

Authors:  R Fienberg
Journal:  Hum Pathol       Date:  1981-05       Impact factor: 3.466

8.  Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis.

Authors:  B Nölle; U Specks; J Lüdemann; M S Rohrbach; R A DeRemee; W L Gross
Journal:  Ann Intern Med       Date:  1989-07-01       Impact factor: 25.391

9.  Bioptic diagnosis of Wegener's granulomatosis in the absence of vasculitis and granulomas.

Authors:  I A Shah; A Holstege; U N Riede
Journal:  Pathol Res Pract       Date:  1984-03       Impact factor: 3.250

10.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

Authors:  R J Falk; J C Jennette
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

View more
  29 in total

1.  Monocyte activation in patients with Wegener's granulomatosis.

Authors:  A C Muller Kobold; C G Kallenberg; J W Tervaert
Journal:  Ann Rheum Dis       Date:  1999-04       Impact factor: 19.103

Review 2.  Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommendations for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results.

Authors:  A Wiik
Journal:  Springer Semin Immunopathol       Date:  2001

Review 3.  Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?

Authors:  Jan Willem Cohen Tervaert; Jan Damoiseaux
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

Review 4.  Pathogenesis of ANCA-associated vasculitis.

Authors:  Rodrigo Cartin-Ceba; Tobias Peikert; Ulrich Specks
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

5.  IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis.

Authors:  Mirjan M van Timmeren; Betty S van der Veen; Coen A Stegeman; Arjen H Petersen; Thomas Hellmark; Mattias Collin; Peter Heeringa
Journal:  J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 10.121

Review 6.  Cogan's syndrome and other ocular vasculitides.

Authors:  Gabriela M Espinoza; Angela Prost
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

Review 7.  Pathogenesis of ANCA-associated vasculitis.

Authors:  Julia Flint; Matthew D Morgan; Caroline O S Savage
Journal:  Rheum Dis Clin North Am       Date:  2010-06-23       Impact factor: 2.670

8.  C-ANCA-positive IgG fraction from patients with Wegener's granulomatosis induces lung vasculitis in rats.

Authors:  W Weidebach; V S T Viana; E P Leon; C Bueno; A S Leme; F M Arantes-Costa; M A Martins; P H N Saldiva; E Bonfa
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

9.  Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3.

Authors:  W J King; D Adu; M R Daha; C J Brooks; D J Radford; A A Pall; C O Savage
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

10.  Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides?

Authors:  A C Muller Kobold; G Mesander; C A Stegeman; C G Kallenberg; J W Tervaert
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.